NCT01991483View on ClinicalTrials.gov

A Study of LY2928057 in Hemodialysis Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

October 31, 2015

Study Completion Date

October 31, 2015

Conditions
Renal Insufficiency, ChronicKidney Disease, Chronic
Interventions
DRUG

LY2928057

Administered intravenously

DRUG

Placebo

Administered intravenously

Trial Locations (4)

32806

Orlando Clinical Research Center, Orlando

46202

Indiana University School of Medicine, Indianapolis

55404

Davita Clinical Research, Minneapolis

80228

Davita Clinical Research, DN, Lakewood

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT01991483 - A Study of LY2928057 in Hemodialysis Participants | Biotech Hunter | Biotech Hunter